The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts
Abstract
Background.: Although the incidence of early acute rejection could have been diminished in the past, the long-term renal allograft survival could not benefit from the introduction of more effective immunosuppressive regimens mainly aiming at cellular rejection mechanisms. The cause of chronic rejection is still discussed controversially. Here, we demonstrate to what extent human leukocyte antigen (HLA) antibodies (HLAab) posttransplant contribute to late graft outcome. Methods.: A total of 1014 deceased kidney transplant recipients transplanted at the Charité hospital were monitored in a cross-sectional manner for the development of HLAab using Luminex Single Antigen beads. Patients with stable kidney function at a median of 5-years posttransplant were tested once for HLAab and monitored for 5.5 years after testing. Results.: Thirty percent of recipients showed HLAab. Donor-specific antibodies (DSA) were found in 31% of antibody positive patients. The presence of DSA was associated with a significantly lower graft survival of 49% vs. 83% in the HLAab negative group ( P ≤0.0001). Non-DSAs also had an adverse effect on graft survival (70% vs. 83%; P =0.0001). In a prospective analysis of 195 patients with repeatedly no detectable HLAab, the survival probability was 94% as opposed to 79% survival among patients who developed HLAab de novo after the first testing ( P =0.05). Conclusions.: We confirmed that HLAab produced even late after transplantation are detrimental to graft outcome. DSA were proven to have a strong adverse impact on graft survival. The results indicate that a posttransplant HLAab monitoring routine could be appropriate to improve long-term results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Meier-Kriesche, H.-U., Schold, J. D., Srinivas, T. R., & Kaplan, B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00332.x · Cited by 1,287
Solez, K., Colvin, R., Racusen, L., Sis, B., Halloran, P., Birk, P., Campbell, P., Cascalho, M., Collins, A., Demetris, A., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01688.x · Cited by 1,082
Humoral Theory of Transplantation
Terasaki, P. I. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00135.x · Cited by 609
Self-citationAntibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis
Colvin, R. B. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010073 · Cited by 517
Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial
Terasaki, P. I., & Ozawa, M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00360.x · Cited by 453
Self-citationPei, R., Lee, J.-H., Shih, N.-J., Chen, M., & Terasaki, P. I. (2003) · Transplantation · doi:10.1097/00007890-200301150-00008 · Cited by 409
Self-citationFour-year Follow-up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival
Terasaki, P., Ozawa, M., & Castro, R. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01644.x · Cited by 362
Self-citationMao, Q., Terasaki, P., Cai, J., Briley, K., Catrou, P., Haisch, C., & Rebellato, L. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01711.x · Cited by 221
Self-citationPascual, M., Saidman, S., Tolkoff-Rubin, N., Williams, W. W., Mauiyyedi, S., Duan, J. M., Farrell, M. L., Colvin, R. B., Cosimi, A. B., & Delmonico, F. L. (1998) · Transplantation · doi:10.1097/00007890-199812150-00008 · Cited by 203
Humoral theory of transplantation: further evidence
Terasaki, P. I., & Cai, J. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.018 · Cited by 189
Self-citationMartin, L., Guignier, F., Mousson, C., Rageot, D., Justrabo, E., & Rifle, G. (2003) · Transplantation · doi:10.1097/01.tp.0000078895.24606.45 · Cited by 136
Humoral Theory of Transplantation: Mechanism, Prevention, and Treatment
Cai, J., & Terasaki, P. I. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.01.021 · Cited by 109
Self-citationAdeyi, O. A., Girnita, A. L., Howe, J., Marrari, M., Awadalla, Y., Askar, M. Z., Martell, J., Zeevi, A., Shapiro, R., Nalesnik, M. A., et al. (2005) · Transplant Immunology · doi:10.1016/j.trim.2005.01.001 · Cited by 106
Vongwiwatana, A., Gourishankar, S., Campbell, P. M., Solez, K., & Halloran, P. F. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00294.x · Cited by 88
Anti-HLA Class I Antibodies Activate Endothelial Cells and Promote Chronic Rejection
Jin, Y., Jindra, P., Gong, K., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000153293.39132.44 · Cited by 82
Frequency of MIC Antibody in Rejected Renal Transplant Patients without HLA Antibody
Mizutani, K., Terasaki, P. I., Shih, R. N. J., Pei, R., Ozawa, M., & Lee, J.-H. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.007 · Cited by 76
Self-citationCai, J., Terasaki, P. I., Mao, Q., Pham, T. D., El-Awar, N. R., Lee, J.-H., & Rebellato, L. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01560.x · Cited by 74
Self-citationAnalysis of HLA Class I Specific Antibodies in Patients with Failed Allografts
Mao, Q., Terasaki, P. I., Cai, J., El-Awar, N. R., & Rebellato, L. M. (2007) · Transplantation · doi:10.1097/01.tp.0000250492.55775.83 · Cited by 48
Self-citation
Cited by
Wiebe, C., Gibson, I. W., Blydt-Hansen, T. D., Karpinski, M., Ho, J., Storsley, L. J., Goldberg, A., Birk, P. E., Rush, D. N., & Nickerson, P. W. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04013.x · Cited by 950
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Loupy, A., Lefaucheur, C., Vernerey, D., Prugger, C., van Huyen, J.-P. D., Mooney, N., Suberbielle, C., Frémeaux-Bacchi, V., Méjean, A., Desgrandchamps, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302506 · Cited by 852
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
Self-citationSis, B., Mengel, M., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Baldwin, W. M., Bracamonte, E. R., Broecker, V., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02987.x · Cited by 762
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
Brunet, M., van Gelder, T., Åsberg, A., Haufroid, V., Hesselink, D. A., Langman, L., Lemaitre, F., Marquet, P., Seger, C., Shipkova, M., et al. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000640 · Cited by 707
Self-citation
Metadata
- Authors
- Lachmann, N., Terasaki, P. I., Budde, K., Liefeldt, L., Kahl, A., Reinke, P., Pratschke, J., Rudolph, B., Schmidt, D., Salama, A., & Schönemann, C.
- Venue
- Transplantation
- Published
- 2009-05-27
- Volume
- 87
- Issue
- 10
- Pages
- 1505-1513
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2067863998
- Cited by
- 344
- References
- 20
- FWCI
- 16.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.